Latest Market News

May 01
Phillips 66 resumes $2.5 billion share buyback program

Phillips 66 PSX, -0.52% said Friday it’s re-starting its $2.5 billion share buyback program after suspending it in March 2020 to preserve liquidity. Under the plan, the company may repurchase its outstanding shares of common stock from time to time in open market or privately negotiated transactions. Repurchases will be at management’s discretion and subject […]

May 01
Colgate-Palmolive shares slide premarket as company says difficult cost environment to continue to weigh on profit

Colgate-Palmolive Co. shares CL, -5.13% slid 4% premarket Friday, after profit fell in the first quarter and company warned of continued pressure from inflation and geopolitical concerns. The consumer goods giant posted net income of $559 million, or 66 cents a share, for the quarter, down from $681 million, or 80 cents a share, in […]

May 01
Charter tops profit estimates, adds 373,000 mobile lines

Charter Communications Inc. CHTR, -7.15% exceeded profit expectations for its first quarter while pointing to growth in residential and mobile revenue. Charter posted net income of $1.2 billion, or $6.90 a share, up from $807 million, or $4.11 a share, in the year-prior quarter. The FactSet consensus was for $6.54 per share in earnings. Revenue […]

May 01
Outback parent beats on earnings, raises guidance

Bloomin’ Brands Inc. BLMN, -0.05% stock soared 6.4% in Friday premarket trading after it reported a first-quarter earnings beat and raised its guidance. The restaurant company posted net income totaling $75.5 million, or 73 cents per share, up from $70.2 million, or 63 cents per share, last year. Adjusted EPS of 80 cents beat the […]

May 01
Liquidity has driven DeFi’s growth to date, so what’s the future outlook?

In mid-February 2020, the total value locked within decentralized finance (DeFi) applications first exceeded $1 billion. Fueled by the DeFi summer of 2020, it wouldn’t even take a year before it multiplied 20-fold to reach $20 billion and only another ten months to reach $200 billion. Given the pace of growth so far, it doesn’t […]

May 01
Bristol Myer Squibb’s stock falls after cutting adjusted EPS for 2022

Shares of Bristol Myers Squibb Co. BMY, -2.50% were down 1.9% in premarket trading on Friday after the company told investors to expect less revenue from its cancer drug Revlimid and lower adjusted EPS for the full year of 2022. Bristol had net income of $1.2 billion, or 59 cents per share, in the first […]